sulbactam and quinine
sulbactam has been researched along with quinine in 4 studies
Compound Research Comparison
Studies (sulbactam) | Trials (sulbactam) | Recent Studies (post-2010) (sulbactam) | Studies (quinine) | Trials (quinine) | Recent Studies (post-2010) (quinine) |
---|---|---|---|---|---|
1,844 | 297 | 488 | 6,859 | 398 | 1,099 |
Protein Interaction Comparison
Protein | Taxonomy | sulbactam (IC50) | quinine (IC50) |
---|---|---|---|
Solute carrier family 22 member 1 | Mus musculus (house mouse) | 0.28 | |
Solute carrier family 22 member 2 | Mus musculus (house mouse) | 2.8 | |
Potassium channel subfamily K member 2 | Homo sapiens (human) | 3.85 | |
ATP-dependent translocase ABCB1 | Homo sapiens (human) | 1.7 | |
Cytochrome P450 2D26 | Rattus norvegicus (Norway rat) | 0.094 | |
Cytochrome P450 2D6 | Homo sapiens (human) | 0.6285 | |
Solute carrier family 22 member 1 | Rattus norvegicus (Norway rat) | 2.0333 | |
Cytochrome P450 2D4 | Rattus norvegicus (Norway rat) | 1.7 |
Research
Studies (4)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Borek, AP; Dressel, DC; Hussong, J; Peterson, LR | 1 |
Other Studies
4 other study(ies) available for sulbactam and quinine
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Evolving clinical problems with Streptococcus pneumoniae: increasing resistance to antimicrobial agents, and failure of traditional optochin identification in Chicago, Illinois, between 1993 and 1996.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Bacteremia; Cerebrospinal Fluid; Chicago; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Erythromycin; Humans; Male; Microbial Sensitivity Tests; Penicillins; Pneumococcal Infections; Quinine; Respiratory System; Streptococcus pneumoniae; Sulbactam | 1997 |